MarketInOut Stock Screener Log In | Sign Up
 

Aethlon Medical Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/02/2026
Aethlon Medical Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4.54 mln
Float0.71 mln
Earnings Date11/18/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

13.25
Transformational upside

Relative Strength

80 / 100
Strongly outperforming

Debt / Equity

0.05
Debt-free

ROE

-134
Deeply negative

ROA

-104
Deeply negative

Business Description

Founded in 1984 and headquartered in San Diego, California, Aethlon Medical is working to bring a new kind of treatment device to patients fighting cancer or dangerous viral infections. The company's main product, the Hemopurifier, is currently in clinical trials and is also being explored for use in organ transplantation. By filtering harmful agents from the blood, this device aims to support the body's natural ability to fight disease.

Key Fundamentals

EPS-14.65
ROE-134
ROIC-533
ROA-104
Interest Cover-493
EBITDA, mln-6.61
EV / EBITDA0.44
EV / EBIT0.42

Quote Details

Last 6.45
Change -0.18 (-2.71%)
Open 6.54
Volume 40,813
Turnover 263,244
Average Volume 4,678,260

Financial Ratios

Leverage Ratio1.20
Current Ratio5.42
Price / Book0.23
Price / Tangible Book0.23
Debt / Equity0.05

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price13.25
Short Ratio0.02
Short % of Float10.54

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.71% 88 / 100   
1 Month 254% 100 / 100   
2 Months 47.6% 96 / 100   
6 Months -39.15% 11 / 100   
1 Year -82.3% 7 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us